Pan American Energy Commences the Spring 2024 Field Prospecting and Sampling Program At The Big Mack Lithium Project
May 13, 2024 08:00 ET
|
Pan American Energy Corp.
CALGARY, Alberta, May 13, 2024 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (CSE: PNRG | OTCQB: PAANF | FRA: SS60) ("Pan American” or the "Company") is pleased to announce the commencement of the...
Genius Group Schedules Full Year 2023 Earnings Call Thursday, May 16, 2024 at 8:30am ET
May 13, 2024 08:00 ET
|
Genius Group Limited
Singapore, May 13, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) ("Genius Group" or the "Company"), a leading provider of AI-powered, digital-first education solutions, will...
Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 13, 2024 08:00 ET
|
Prime Medicine, Inc.
CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
May 13, 2024 08:00 ET
|
Disc Medicine Inc
WATERTOWN, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel...
Recce Pharmaceuticals Reports Positive Preclinical Data of RECCE® 327 in Lung Infection Pilot Study
May 13, 2024 08:00 ET
|
Recce Pharmaceuticals
RECCE® 327 (R327) demonstrated >99% log reduction (>2.5 log reduction) in Mycobacterium abscessus lung infections using a nebulizer delivery methodR327 is being evaluated for potential use to...
Verde Bio and SensaSure Technologies Complete Merger to Create Premier Mineral Acquisitions Company
May 13, 2024 08:00 ET
|
VERDE BIO HLDGS INC.
Verde Bio and SensaSure Technologies Complete Merger to Create Premier Mineral Acquisitions Company
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 13, 2024 08:00 ET
|
GRI Bio, Inc.
Interim data readout of Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) expected Q3 2024 and topline data on track for Q4 2024 ...
Reviva to Present New Preclinical Efficacy Data on Brilaroxazine in Idiopathic Pulmonary Fibrosis at 2024 ATS International Conference
May 13, 2024 08:00 ET
|
Reviva Pharmaceuticals
CUPERTINO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that...
BairesDev CEO Recognized as a Technology Executive of the Year in 2024 American Business Awards®
May 13, 2024 08:00 ET
|
BairesDev
MOUNTAIN VIEW, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Nacho De Marco, CEO of BairesDev®, an award-winning software outsourcing company, is honored with a Silver Stevie® Award in the Technology...
Global Smart Agriculture Market Size, Share, Growth at a CAGR of 9.4%
May 13, 2024 08:00 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 13, 2024 (GLOBE NEWSWIRE) -- The global smart agriculture market size is projected to reach USD 25.4 billion by 2028 from an estimated USD 16.2 billion in 2023, at a CAGR of 9.4% from...